A carregar...

Developing Antiepileptogenic Drugs for Acquired Epilepsy: Targeting the Mammalian Target of Rapamycin (mTOR) Pathway

While current medications for epilepsy are primarily symptomatic treatments that suppress seizures, one of the main goals of future drug development in epilepsy is the identification of antiepileptogenic or disease-modifying therapies that can completely prevent epilepsy or slow its progression. A r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zeng, Ling-Hui, Rensing, Nicholas R., Wong, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2858431/
https://ncbi.nlm.nih.gov/pubmed/20419051
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!